The role of microRNA in resistance to breast cancer therapy
Abstract
MicroRNAs (miRNAs) are small noncoding RNA molecules with big implications in cancer. The abnormal expression of specific miRNAs has been linked to development of many cancer types. Dysregulated miRNAs play a significant role in proliferation, invasion, differentiation, apoptosis, and resistance of various cancer cells, and considered as oncogenes or tumor‐suppressor genes. Findings have shown abnormal expression of specific miRNAs in breast tumors is a strong indication about the resistance to conventional cancer therapy methods. Acquired cancer resistance is a complex, multifactorial occurrence that requires various mechanisms and processes, however, recent studies have suggested that resistance may be linked to treatment‐induced dysregulation of miRNAs. This dysregulation of miRNAs can affect the protein expression in cells, the ability for anti‐cancer drugs to reach their targets within cells, and the apoptotic pathways. Controlling the expression of these miRNAs alters the resistant phenotype of breast cancer to a nonresistant one. This review focuses on the role of dysregulated miRNAs in breast cancer that are linked to resistance against chemo‐, radiation, hormone, and targeted therapies. Finally, the role of miRNAs in breast cancer metastasis is briefly discussed. WIREs RNA 2014, 5:823–833. doi: 10.1002/wrna.1248This article is categorized under: RNA in Disease and Development > RNA in DiseaseKeywords
Funding Information
- States University of New York StartUp Funds
This publication has 60 references indexed in Scilit:
- MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9Cancer Letters, 2014
- MicroRNA-148a: A potential therapeutic target for cancerGene, 2014
- MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3Cancer Letters, 2014
- MicroRNA‐221 promotes colorectal cancer cell invasion and metastasis by targeting RECKFEBS Letters, 2013
- MicroRNA-21 in breast cancer: diagnostic and prognostic potentialClinical and Translational Oncology, 2013
- Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasisOncogene, 2013
- MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1Oncogene, 2013
- Role of miR-10b in breast cancer metastasisBreast Cancer Research, 2010
- MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancerOncogene, 2007
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006